Shane Stecklein

7PUBLICATIONS
72CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersScience, technology and engineering curriculum and pedagogy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 11, 2026
Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2).

|Jun 10, 2024
In Vivo Simvastatin and Brain Radiation in a Model of HER2 + Inflammatory Breast Cancer Brain Metastasis.

Swaminathan Kumar, Richard A Larson, Shane Stecklein

|Mar 11, 2024
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy.

Miguel Martín, Rachel Yoder, Roberto Salgado

|Nov 16, 2023
Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency.

Shane R Stecklein, William Barlow, Lajos Pusztai

|Mar 06, 2023
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.

Shane R Stecklein, Bruce F Kimler, Rachel Yoder

|Jul 11, 2022
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer.

Rachel Yoder, Bruce F Kimler, Joshua M Staley

Pageof 2

Frequent Collaborators

4 joint publications

Priyanka Sharma

4 joint publications

Andrew K Godwin

3 joint publications

Qamar J Khan

3 joint publications

Joshua M Staley